GPC1 and pancreatic neoplasm: For example, Melo et al. (2015) found increased glypican-1 (GPC1) levels in EVs isolated from the blood of patients with early-stage pancreatic cancer, and proposed that circulating GPC1+ exosome levels could predict the stage of pancreatic cancer (Melo et al., 2015).